Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 2013, 275172

Influence of Mast Cells in Drug-Induced Gingival Overgrowth

Affiliations

Influence of Mast Cells in Drug-Induced Gingival Overgrowth

Tamilselvan Subramani et al. Mediators Inflamm.

Abstract

Mast cells (MCs) are multifunctional effector cells that were originally thought to be involved in allergic disorders. Now it is known that they contain an array of mediators with a multitude of effects on many other cells. MCs have become a recent concern in drug-induced gingival overgrowth (DIGO), an unwanted outcome of systemic medication. Most of the studies have confirmed the significant presence of inflammation as a prerequisite for the overgrowth to occur. The inflammatory changes within the gingival tissue appear to influence the interaction between the inducing drug and the fibroblast activity. The development of antibodies to MC-specific enzymes, tryptase and chymase, has facilitated the study of mast cells in DIGO. Many immunohistochemical studies involving MCs have been conducted; as a result, DIGO tissues are found to have increased the number of MCs in the gingiva, especially in the area of fibrosis. At the cellular level, gingival fibrogenesis is initiated by several mediators which induce the recruitment of a large number of inflammatory cells, including MCs. The purpose of this paper is to access the roles played by MCs in gingival overgrowth to hypothesize a relationship between these highly specialized cells in the pathogenesis of DIGO.

Figures

Figure 1
Figure 1
Figure 2
Figure 2

Similar articles

See all similar articles

Cited by 6 PubMed Central articles

See all "Cited by" articles

References

    1. Dongari A, McDonnell HT, Langlais RP. Drug-induced gingival overgrowth. Oral Surgery Oral Medicine and Oral Pathology. 1993;76(4):543–548. - PubMed
    1. Thomason JM, Seymour RA, Rice N. The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth. Journal of Clinical Periodontology. 1993;20(1):37–40. - PubMed
    1. Sano M, Ohuchi N, Inoue T, et al. Proliferative response to phenytoin and nifedipine in gingival fibroblasts cultured from humans with gingival fibromatosis. Fundamental and Clinical Pharmacology. 2004;18(4):465–470. - PubMed
    1. Seymour RA, Thomason JM, Ellis JS. The pathogenesis of drug-induced gingival overgrowth. Journal of Clinical Periodontology. 1996;23(3):165–175. - PubMed
    1. Seymour RA, Ellis JS, Thomason JM. Risk factors for drug-induced gingival overgrowth. Journal of Clinical Periodontology. 2000;27(4):217–223. - PubMed

LinkOut - more resources

Feedback